Clorox Co. diskutieren

The Clorox Company (NYSE: CLX) had its price target raised by analysts at Barclays PLC from $130.00 to $137.00. They now have an "underweight" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Evercore ISI from $140.00 to $139.00. They now have an "underperform" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target raised by analysts at Barclays PLC from $137.00 to $139.00. They now have an "underweight" rating on the stock.

Hey there! So, I've been keeping an eye on Clorox, and I've got to say, things are looking up. You know how we all love a good comeback story, right? Well, Clorox might just be writing one. Their relative strength rating just got a nice boost, jumping from 67 to 76. It's like they've been hitting the gym and now they're flexing those financial muscles! This could be a sign that Clorox is ready to clean up (pun intended) in the market. Sure, past performance doesn't guarantee future results, but this improved rating suggests Clorox might have some tricks up its sleeve. With the current price at 157.4, I'm thinking there's room for growth. It's like Clorox is a runner who's just found their second wind - they might be picking up the pace. What do you think? Could Clorox be the dark horse in your portfolio? It might be worth considering if you're looking to freshen up your investments!

The Clorox Company (NYSE: CLX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Barclays PLC from $139.00 to $130.00. They now have an "underweight" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target raised by analysts at Barclays PLC from $130.00 to $140.00. They now have an "underweight" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Barclays PLC from $140.00 to $139.00. They now have an "underweight" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Barclays PLC from $139.00 to $134.00. They now have an "underweight" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Barclays PLC from $134.00 to $129.00. They now have an "underweight" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Jefferies Financial Group Inc. from $167.00 to $145.00. They now have a "buy" rating on the stock.

The Clorox Company (NYSE: CLX) had its price target lowered by analysts at Barclays PLC from $129.00 to $119.00. They now have an "underweight" rating on the stock.

Clorox (NYSE:CLX) had its price target lowered by analysts at Barclays PLC from $118.00 to $112.00. They now have an "underweight" rating on the stock.

Clorox (NYSE:CLX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $115.00 to $110.00. They now have a "sell" rating on the stock.

Clorox (NYSE:CLX) had its price target lowered by analysts at BNP Paribas Exane from $118.00 to $110.00. They now have an "underperform" rating on the stock.

Clorox (NYSE:CLX) had its price target lowered by analysts at Barclays PLC from $112.00 to $108.00. They now have an "underweight" rating on the stock.

Clorox (NYSE:CLX) had its price target lowered by analysts at BNP Paribas Exane from $110.00 to $103.00. They now have an "underperform" rating on the stock.

Clorox (NYSE:CLX) had its "underweight" rating reaffirmed by analysts at Barclays PLC.

Clorox (NYSE:CLX) had its price target lowered by analysts at BNP Paribas Exane from $103.00 to $101.00. They now have an "underperform" rating on the stock.